Take Action With the Respect to any Abbreviated New Drug Application ("ANDA") Referencing Ventavis | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2013-P-0424

Take Action With the Respect to any Abbreviated New Drug Application ("ANDA") Referencing Ventavis

Documents

Comments

Description

CLOSED

Comment Period OpensApr 24, 2013

Type	Title	Posted	Comments	Status
Other	Final Response Letter from FDA CDER to Actelion Pharmaceuticals Ltd.	Jul 10, 2026	--

Total Comments

cder

2013-2599

ventavis

ANDA

inhalation

solution

iloprost

inhaled drug

pulmonary